Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-02-25 @ 9:46 PM
Study NCT ID:
NCT05118360
Status:
WITHDRAWN
Last Update Posted:
2024-09-27
First Post:
2021-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
Sponsor:
Gannex Pharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-11-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-01
First Submit QC Date:
None
Study First Post Date:
2021-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-25
Last Update Post Date:
2024-09-27
Last Update Post Date Type:
ACTUAL